Physician profile
Eric E Johnson
NPI 1447342811
$58,710.73
in general payments reported to CMS, 2019-2025
43 companies · $10K in 2025
The $10K reported for 2025 was more than what 80% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,328 · 2021: $4,395 · 2022: $11K · 2023: $12K · 2024: $9,027 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Travel and Lodging: $12K · Consulting Fee: $4,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,082.48 |
| Travel and Lodging | $11,998.13 |
| Consulting Fee | $4,375.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $29,060.06 | 2021-2025 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $9,802.50 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $5,505.07 | 2019-2025 | Ensite, Tacticath Ablation Catheter, Sensor Enabled, Aveir |
| Medtronic Vascular, INC. | $4,322.63 | 2019-2020 | |
| Boston Scientific Corporation | $2,508.82 | 2019-2025 | Watchman Access System, Rhythmia Mapping System, Lux-Dx Insertable Cardiac Monitor |
| Novartis Pharmaceuticals Corporation | $1,485.33 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $679.10 | 2022-2025 | Optimizer, Optimizer |
| Astrazeneca Pharmaceuticals Lp | $564.61 | 2022-2025 | Wainua, Farxiga, Andexxa |
| Actelion Pharmaceuticals US, INC. | $420.14 | 2019-2023 | Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $406.49 | 2019-2025 | Jardiance |
| Cardiva Medical, INC. | $382.11 | 2020-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Cvrx, INC. | $358.36 | 2021-2025 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $345.07 | 2022-2025 | Verquvo, Capvaxive |
| Sanofi-Aventis U.S. LLC | $320.22 | 2019-2024 | |
| Pfizer INC. | $290.31 | 2019-2024 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $245.45 | 2024-2025 | Wegovy, Ozempic |
| Amgen INC. | $210.60 | 2019-2024 | Repatha |
| Alnylam Pharmaceuticals INC. | $178.47 | 2023-2025 | Amvuttra |
| Bardy Diagnostics, INC. | $170.00 | 2021-2022 | |
| Philips North America LLC | $165.72 | 2020-2025 | Ambulatory Monitoring & Diagnostics Undivided, Extended Holter, (Cm9) Amb Mon & Diag Und |
| Biotronik INC. | $158.04 | 2019-2025 | Pamira, Amvia Edge, Biomonitor |
| Abiomed | $157.86 | 2023-2025 | Impella |
| Edwards Lifesciences Corporation | $140.53 | 2022 | |
| Cordis US Corp. | $111.90 | 2024-2025 | Mynx Control |
| Biosense Webster, INC. | $88.84 | 2019-2024 | Carto 3 |
| Vivaquant INC, Dba Rhythm Express | $88.44 | 2024-2025 | Rhythm Express, Rhythm Express |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.70 | 2024-2025 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $50.32 | 2023-2024 | |
| Kowa Pharmaceuticals America, INC. | $48.23 | 2019-2024 | Livalo |
| Janssen Pharmaceuticals, INC | $42.62 | 2020-2022 | |
| Esperion Therapeutics, INC. | $35.65 | 2025 | Nexletol |
| Akcea Therapeutics, INC. | $35.05 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.08 | 2023 | |
| Irhythm Technologies, INC. | $32.05 | 2019 | |
| Atricure, INC. | $30.28 | 2022-2023 | |
| Bridgebio Pharma, INC. | $23.56 | 2025 | Attruby |
| Ge Healthcare | $21.67 | 2023 | |
| Altathera Pharmaceuticals LLC | $21.27 | 2023 | Sotalol Hydrochloride |
| Amarin Pharma, INC. | $18.56 | 2023 | |
| Portola Pharmaceuticals, LLC | $17.00 | 2019 | |
| Elutia, INC. | $16.86 | 2025 | Ecm Patch,Pouch |
| Vifor Pharma, INC. | $16.34 | 2019 | |
| Baxter Healthcare | $15.82 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.